ProCE Banner Activity

Emerging Data for Ongoing Trials in First-Line mBC and Experts Recommendations for Addressing Clinical Challenges With ADCs

Slideset

Download these slides from a live webinar covering key trials of first-line therapy for patients with HER2-positive metastatic breast cancer, including expert’s review of the clinical data for the management of ADC-related adverse events.

Released: May 13, 2025

Expiration: November 12, 2025

Share

Provided by

Provided by Clinical Care Options, LLC. in partnership with Smart Patients.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Smart Patients

ProCE Banner